Send Message
ALP Rapid Test Cassette Urine 100ng/M Cut-Off Detection Of Alprazolam Xanax

ALP Rapid Test Cassette Urine 100ng/M Cut-Off Detection Of Alprazolam Xanax

  • High Light

    100ng/M ALP Rapid Test Cassette


    ALP Rapid Test Cassette Urine


    Citest Drug Abuse Test Kit

  • Product Name
    ALP Rapid Test Cassette (Urine), 100ng/m Cut-off, Detection Of Alprazolam, Xanax
  • Cat No.
  • Principle
    Chromatographic Immunoassay
  • Specimen
  • Pack
    40 T/50 T
  • Sensitivity
  • Specificity
  • Accuracy
  • Cut-Off
    100 Ng/mL*
  • Format
    Dipstick, Cassette, Panel, Cup
  • Reading Time
    5 Minutes
  • Place of Origin
  • Brand Name
  • Certification
  • Model Number
  • Minimum Order Quantity
  • Price
  • Packaging Details
    40 T/50 T
  • Delivery Time
    2-4 Weeks
  • Supply Ability
    10 M tests/month

ALP Rapid Test Cassette Urine 100ng/M Cut-Off Detection Of Alprazolam Xanax

ALP Rapid Test Cassette (Urine), 100ng/m cut-off, detection of alprazolam, Xanax



A rapid test for the qualitative detection of Alprazolam in human urine. For medical and other professional in vitro diagnostic use only.
Principle Chromatographic Immunoassay
Format Dipstick, Cassette, Panel, Cup
Specimen Urine
Certificate CE
Reading Time 5 minutes
Pack 40T/50T
Storage Temperature 2-30°C
Shelf Life 2 Years
Sensitivity 90.90%
Specificity 97.40%
Accuracy 95.90%
Cut-Off 100 ng/mL*



The ALP Rapid Test Cassette (Urine) is a rapid chromatographic immunoassay for the detection of alprazolam in urine at a cut-off concentration of 100ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.
This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Alprazolam, available under the trade name Xanax among others, is a short-acting anxiolytic of the benzodiazepine class. It is commonly used for the treatment of panic disorder, and anxiety disorders, such as generalized anxiety disorder (GAD) or social anxiety disorder (SAD).1,2 Alprazolam, like other benzodiazepines, binds to specific sites on the GABAA receptor. It possesses anxiolytic, sedative, hypnotic, skeletal muscle relaxant, anticonvulsant, and amnestic properties.
A mean half-life of alprazolam of 16.3 hours has been observed in healthy elderly subjects (range: 9.0-26.9 hours, n=16) compared to 11.0 hours (range: 6.3-15.8 hours, n=16) in healthy adult subjects. Alprazolam and its metabolites are excreted primarily in the urine. The pharmacokinetics of alprazolam and two of its major active metabolites (4-hydroxyalprazolam and α-hydroxyalprazolam) are linear, and concentrations are proportional up to the recommended maximum daily dose of 10 mg given once daily. 
Peak concentrations in the plasma occur in one to two hours following administration. Plasma levels are proportionate to the dose given; over the dose range of 0.5 to 3.0 mg, peak levels of 8.0 to 37ng/ml were observed. 
The ALP Rapid Test Cassette (Urine) is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody.
During testing, a urine specimen migrates upward by capillary action. Alprazolam, if present in the urine specimen below the cut-off level, will not saturate the binding sites of the antibody in the test. The antibody coated particles will then be captured by immobilized alprazolam-protein conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if Alprazolam level exceeds the cut-off level, because it will saturate all the binding sites of anti- Alprazolam antibody.
A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration less than the cut-off will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
The test contains mouse monoclonal anti- Alprazolam antibody coupled particles and alprazolam -protein conjugate. A goat antibody is employed in the control line system.


Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test cassette from the sealed pouch and use it within one hour.
2. Place the test device on a clean and level surface. Hold the dropper vertically and transfer 3 full drops of urine (approx. 120 µL) to the specimen well (S) of the test cassette, and then start the timer. Avoid trapping air bubbles in the specimen well (S). See the illustration below.
3. Wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10 minutes.
ALP Rapid Test Cassette Urine 100ng/M Cut-Off Detection Of Alprazolam Xanax 0
A procedural control is included in the test. A colored line appearing in the control line region (C) is  considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit; however, it is recommended that positive and negative controls be tested as good laboratory testing practice to confirm the test procedure and to verify proper test performance.